Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients Diagnosed With Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03787966
What this trial is testing

Attenuating Cancer Treatment-related Toxicity in Oncology Patients With a Tailored Physical Exercise Program

Who this might be right for
Breast Neoplasms
Universidad de Granada 100
Early research (Phase 1)Study completedNCT00005796
What this trial is testing

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ
Indiana University 10
Testing effectiveness (Phase 2)Ended earlyNCT06359379
What this trial is testing

Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter

Who this might be right for
Glioblastoma, IDH-wildtype
Shuttle Pharmaceuticals, Inc. 30
Testing effectiveness (Phase 2)Looking for participantsNCT04977180
What this trial is testing

Cardioprotection in AML

Who this might be right for
AMLAcute Myeloid Leukemia
University of Virginia 70
Testing effectiveness (Phase 2)Study completedNCT02794805
What this trial is testing

Determination of HCC With Octanoate Breath Test vs. MRI Diagnosis

Who this might be right for
Hepatocellular Carcinoma (HCC)
Meridian Bioscience, Inc. 74
Early research (Phase 1)Study completedNCT03514069
What this trial is testing

Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma

Who this might be right for
GliomaGlioblastoma
Case Comprehensive Cancer Center 60
Testing effectiveness (Phase 2)Ended earlyNCT00038142
What this trial is testing

Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients

Who this might be right for
Ewing's Sarcoma
M.D. Anderson Cancer Center 46
Early research (Phase 1)Study completedNCT00390403
What this trial is testing

Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT07712588
What this trial is testing

Birelentinib Plus R-CHOP in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (TAI-SHAN19)

Who this might be right for
Diffuse Large B-Cell Lymphoma (DLBCL)
Dizal Pharmaceuticals 880
Not applicableLooking for participantsNCT06994208
What this trial is testing

Characteristics of Adult Patients With Melanoma Diagnosis <40 Years Age.

Who this might be right for
Melanoma of Skin
Ente Ospedaliero Ospedali Galliera 25
Not applicableEnded earlyNCT01052376
What this trial is testing

Endomicrocancer: Confocal Endomicroscopy in Patients With High Risk of Colorectal Cancer

Who this might be right for
Inflammatory Bowel Disease (IBD)Familial Adenomatous Polyposis
Nantes University Hospital 73
Not applicableStudy completedNCT00899210
What this trial is testing

Matrix Metalloproteinases After Surgery and/or Radiofrequency Ablation in Patients With Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
University Hospital, Grenoble 75
Testing effectiveness (Phase 2)Study completedNCT02586038
What this trial is testing

STUDY THAT COMPARE 3 ARM: MLN9708 DEXAMETHASONE, MLN9708 CYCLOPHOSPHAMIDE AND DEXAMETHASONE, MLN9708 THALIDOMIDE AND DEXAMETHASONE FOLLOWED BY MAINTENANCE WITH MLN9708 IN NEWLY DIAGNOSED ELDERLY MULTIPLE MYELOMA PATIENTS

Who this might be right for
Multiple Myeloma
Mario Boccadoro 175
Not applicableUnknownNCT05360758
What this trial is testing

Ibrutinib Adapted to Response in Patients With CLL

Who this might be right for
Chronic Lymphocytic Leukemia
Grupo Argentino de Tratamiento de la Leucemia Aguda 80
Testing effectiveness (Phase 2)Looking for participantsNCT06533748
What this trial is testing

Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma

Who this might be right for
Acute Lymphoblastic LeukemiaLymphoblastic Lymphoma
St. Jude Children's Research Hospital 128
Testing effectiveness (Phase 2)WithdrawnNCT01670084
What this trial is testing

Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia

Who this might be right for
B-cell Adult Acute Lymphoblastic LeukemiaBlastic Phase Chronic Myelogenous LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive+2 more
Mayo Clinic
Testing effectiveness (Phase 2)UnknownNCT05503355
What this trial is testing

A Phase I/II Dose Escalation and Expansion Study of BST-236 Plus Venetoclax in Patients With Unfit Newly Diagnosed AML

Who this might be right for
AML, Adult
BioSight Ltd. 80
Not applicableUnknownNCT04856852
What this trial is testing

Iodine-125 Brachytherapy Together With Chemotherapy in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
The Affiliated Hospital of Qingdao University 84
Large-scale testing (Phase 3)Study completedNCT00103285
What this trial is testing

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaChildhood B Acute Lymphoblastic Leukemia
Children's Oncology Group 5,377
Not applicableStudy completedNCT02719847
What this trial is testing

EBUS TBNA After PET/CT in Diagnosing Patients With Stage I-IIA Non-small Cell Lung Cancer Evaluated for Stereotactic Body Radiation Therapy

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 150
Next Page